Landos Biopharma
Utility Patents

Last updated:

List of all Landos Biopharma patents 10 in total

Status Patent
Grant
Utility: Lanthionine C-like protein 2 ligands, cells prepared therewith, and therapies using same External link
Filling date: 6 Sep 2025 Issue date: 5 Jul 2022
Grant
Utility: Therapies with lanthionine C-like protein 2 ligands and cells prepared therewith External link
Filling date: 6 Sep 2025 Issue date: 14 Dec 2021
Grant
Utility: PLXDC2 ligands External link
Filling date: 6 Sep 2025 Issue date: 23 Nov 2021
Grant
Utility: Lanthionine c-like protein 2 ligands, cells prepared therewith, and therapies using same External link
Filling date: 6 Sep 2025 Issue date: 14 Sep 2021
Grant
Utility: NLRX1 ligands External link
Filling date: 6 Sep 2025 Issue date: 20 Jul 2021
Grant
Utility: Lanthionine synthetase C-like 2-based therapeutics External link
Filling date: 6 Sep 2025 Issue date: 1 Dec 2020
Grant
Utility: Lanthionine synthetase C-like 2-based therapeutics External link
Filling date: 6 Sep 2025 Issue date: 16 Jun 2020
Grant
Utility: NLRX1 ligands External link
Filling date: 6 Sep 2025 Issue date: 9 Jun 2020
Grant
Utility: Lanthionine synthetase C-like 2-based therapeutics External link
Filling date: 6 Sep 2025 Issue date: 3 Dec 2019
Grant
Utility: NLRX1 ligands External link
Filling date: 6 Sep 2025 Issue date: 26 Nov 2019

Showing 1 to 10 of 10 patents.